Q1 EPS Estimates for CVS Health Raised by Leerink Partnrs

CVS Health Co. (NYSE:CVS) – Research analysts at Leerink Partnrs increased their Q1 2025 EPS estimates for CVS Health in a note issued to investors on Wednesday, February 12th. Leerink Partnrs analyst M. Cherny now anticipates that the pharmacy operator will earn $1.62 per share for the quarter, up from their prior forecast of $1.20. Leerink Partnrs has a “Strong-Buy” rating on the stock. The consensus estimate for CVS Health’s current full-year earnings is $5.14 per share. Leerink Partnrs also issued estimates for CVS Health’s Q2 2025 earnings at $1.61 EPS, Q3 2025 earnings at $1.28 EPS, Q4 2025 earnings at $1.37 EPS, FY2025 earnings at $5.88 EPS and FY2026 earnings at $7.16 EPS.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%.

CVS has been the subject of a number of other research reports. Truist Financial raised their target price on shares of CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Piper Sandler cut their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. Barclays increased their price target on shares of CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. Edward Jones upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Finally, Mizuho cut their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $70.00.

CVS Health Price Performance

Shares of NYSE CVS opened at $65.47 on Monday. CVS Health has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a 50 day simple moving average of $51.30 and a two-hundred day simple moving average of $56.03. The company has a market capitalization of $82.39 billion, a price-to-earnings ratio of 16.62, a P/E/G ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

Institutional Trading of CVS Health

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. McIlrath & Eck LLC increased its holdings in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 174 shares during the last quarter. Coppell Advisory Solutions LLC increased its holdings in CVS Health by 17.3% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator’s stock valued at $56,000 after acquiring an additional 189 shares during the last quarter. Integrated Advisors Network LLC increased its holdings in CVS Health by 0.7% in the 3rd quarter. Integrated Advisors Network LLC now owns 27,625 shares of the pharmacy operator’s stock valued at $1,737,000 after acquiring an additional 200 shares during the last quarter. Widmann Financial Services Inc. increased its holdings in CVS Health by 1.8% in the 3rd quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator’s stock valued at $724,000 after acquiring an additional 200 shares during the last quarter. Finally, EagleClaw Capital Managment LLC increased its holdings in CVS Health by 3.4% in the 4th quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator’s stock valued at $275,000 after acquiring an additional 200 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.06%. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.